Blood test confirmed to be 'powerful predictor' for metastatic breast cancer following largest analysis to date
Researchers at Georgetown Lombardi Comprehensive Cancer Center say the number of circulating tumor cells (CTCs) in the blood is a "powerful predictor" to help physicians more reliably assess treatment benefit for patients ...
May 18, 2011
0
0